Does Cigna Cover Zepbound? Understanding Express Scripts, Step Therapy, and Coverage Options

For many people prescribed Zepbound, getting the medication approved by insurance can feel almost as complicated as getting the prescription itself. A doctor can determine that tirzepatide is appropriate, yet the claim may still run into prior authorization requirements, step therapy, formulary restrictions, or an employer-level exclusion.

Cigna adds another layer of complexity because its pharmacy benefits are administered through Express Scripts. That means patients may start with Cigna but ultimately deal with Express Scripts for the actual pharmacy-benefit review.

The good news is that a denial isn't always the end of the road. Depending on your plan, medical history, and reason for treatment, there may be an exception or appeal pathway available.

Here's what to know before submitting a claim, appealing a denial, or paying out of pocket.

Does Cigna Cover Zepbound?

Cigna coverage for Zepbound depends heavily on the specific employer or individual plan. There isn't one universal Cigna policy that applies to every member.

Some commercial plans cover the medication for qualifying patients, while others exclude weight-management medications altogether. Even when Zepbound is covered, patients may have to meet specific eligibility requirements and complete prior authorization or step therapy.

Your first step should therefore be checking your individual plan documents rather than assuming that another Cigna member's experience will apply to you.

Why your specific plan matters

Employer-sponsored insurance can have different formularies, exclusions, deductibles, and authorization rules. Self-funded employers can also choose to exclude anti-obesity medications entirely.

If your plan specifically excludes weight-loss medications, satisfying a prior authorization requirement generally won't override that exclusion. In that situation, the issue isn't whether you medically qualify for Zepbound—the benefit simply isn't included in your plan.

How Cigna and Express Scripts Work Together

One of the biggest sources of confusion is the relationship between Cigna and Express Scripts.

Cigna's pharmacy benefits are administered through Express Scripts, which became part of The Cigna Group following its acquisition by Cigna in 2018. Consequently, a Zepbound pharmacy claim or prior authorization may be processed through Express Scripts even though your insurance card displays Cigna.

This can affect almost every stage of the process.

For example, you might:

Call Cigna and be transferred to Express Scripts
Receive a pharmacy denial from Express Scripts
Have your physician submit a prior authorization through a pharmacy-benefit portal
Receive formulary information through Express Scripts
Need to follow Express Scripts' appeal instructions

Why knowing the difference matters

If your prescription is denied, look carefully at the denial letter.

The letter should tell you:

Why the claim was denied
Whether the issue is prior authorization or formulary status
Whether step therapy is required
Whether an exception is available
How to submit an appeal
Where supporting documentation should be sent

Don't assume every denial is the same. A step-therapy denial requires a different strategy from a complete benefit exclusion.

Understanding Step Therapy for Zepbound

Step therapy requires patients to try one or more lower-cost or preferred medications before the insurer approves another medication.

For some Cigna commercial plans, patients may be required to try another weight-management medication before receiving Zepbound.

A simplified example may look like this:

Step

Medication

Typical requirement

Phentermine or another preferred option

Trial period depending on plan

Semaglutide-based therapy such as Wegovy

Trial at an appropriate dose

Zepbound

Approval after requirements are satisfied

The exact medications, duration, and requirements vary by plan.

That's important because there is no guarantee that every Cigna member will face the same sequence.

Why Wegovy can become part of the process

One of the more frustrating requirements for patients is being asked to try Wegovy before Zepbound.

Both medications are used for chronic weight management, but they are not identical. They contain different active ingredients and have different pharmacologic profiles.

If you've already tried semaglutide and experienced inadequate results or significant intolerance, that history may be useful when requesting an exception.

Step-Therapy Exceptions Can Make a Difference

A step-therapy requirement doesn't necessarily mean you must repeat a medication you've already tried.

Depending on your plan, an exception may be considered when:

You've previously tried the required medication
The medication was ineffective
You experienced significant adverse effects
The medication is medically inappropriate for you
Your physician believes the required treatment is unlikely to work
A medical contraindication exists

The important part is documentation.

Instead of simply stating that you don't want to try another medication, your provider should explain why the required step is inappropriate based on your individual medical history.

Submit the exception early

If your physician already knows that you have previously tried another GLP-1 medication, don't necessarily wait for a denial before addressing it.

Ask whether the prior authorization submission can include documentation supporting an exception at the same time.

That can potentially avoid unnecessary back-and-forth and shorten the approval process.

Common Prior Authorization Requirements

Exact criteria vary by plan, but insurers commonly consider several factors when reviewing weight-management prescriptions.

These may include:

Your age
Current BMI
Weight-related medical conditions
Previous weight-management efforts
Previous medication trials
Response to those medications
Current medications
Whether another GLP-1 medication is being used simultaneously
Continued lifestyle-management efforts

A plan may also require documentation of weight loss before approving continued treatment.

BMI requirements

Many insurance policies use BMI as part of their eligibility criteria.

A typical structure may involve:

BMI of 30 or higher, or
BMI of 27 or higher with at least one qualifying weight-related condition

However, these requirements can change between plans, so your own benefit documents and authorization criteria should be treated as the final reference.

Reauthorization Can Be Just as Important as Initial Approval

Getting the first approval doesn't necessarily guarantee coverage indefinitely.

Some plans require a new authorization after several months. At that point, your physician may need to document that the medication is producing meaningful clinical benefit.

A plan could require a specific percentage of weight loss from baseline, although the exact threshold and timeframe vary.

This makes accurate documentation important from the beginning.

Your provider should keep records of:

Starting weight
Starting BMI
Treatment date
Dose progression
Weight changes
Treatment response
Relevant clinical outcomes
Any significant tolerability issues

Don't wait until the insurance company requests this information to start documenting it.

Employer Exclusions Can Override the Entire Process

This is one of the most important distinctions to understand.

There is a major difference between:

"Zepbound requires prior authorization"

and

"Weight-loss medications are excluded from your plan."

In the first situation, you may be able to satisfy the requirements or request an exception.

In the second, there may be no authorization pathway under that benefit.

Check your Summary Plan Description

If your employer provides your insurance, review your Summary Plan Description or pharmacy-benefit documents.

Look for language involving:

Weight-loss medications
Anti-obesity medications
Obesity treatment
Lifestyle medications
Excluded drugs
Pharmacy exclusions

If anti-obesity medications are explicitly excluded, calling repeatedly for a prior authorization may not solve the problem.

Instead, the issue becomes a benefits question that may need to be addressed with your employer's benefits department during a future plan-renewal period.

How Much Could You Pay?

Your out-of-pocket cost can vary dramatically depending on your insurance arrangement.

Coverage situation

Potential cost

What affects it

Covered with fixed copay

Relatively low

Copay and formulary tier

Covered but deductible not met

Potentially much higher

Remaining deductible

Manufacturer savings program

Potentially reduced

Eligibility and program terms

Insurance denial

Full self-pay price

Manufacturer pricing

Compounded alternative

Often lower cash price

Pharmacy and provider

Don't assume that the price shown by a pharmacy is your final cost. Your deductible, formulary tier, manufacturer programs, and eligibility can all change the amount you actually pay.

What If Cigna Denies Your Prescription?

First, identify why it was denied.

Don't immediately assume the solution is an appeal.

Denial because of step therapy

Ask your physician whether you qualify for a step-therapy exception.

Provide documentation of previous medication trials, inadequate response, intolerance, or contraindications.

Denial because of prior authorization

Review the missing criteria. Sometimes the insurer simply needs additional information from the prescribing physician.

Your provider may need to submit:

BMI documentation
Medical history
Previous treatment history
Weight-management records
Medication history
Clinical rationale

Denial because of a benefit exclusion

This is a different situation.

If your employer's plan excludes anti-obesity medications, a medical appeal may not change the result because the medication isn't included in the benefit.

In that case, ask whether another covered indication applies or investigate legitimate self-pay alternatives.

Could Sleep Apnea Change Coverage?

The FDA's approval of Zepbound for certain adults with obesity and moderate-to-severe obstructive sleep apnea created another potential coverage pathway.

This is particularly relevant for patients whose insurance excludes weight-loss medications but covers medications under other approved indications.

For patients with obstructive sleep apnea, insurers may use criteria involving:

A documented diagnosis
Sleep-study results
BMI requirements
Appropriate medical documentation
Previous treatment such as CPAP, depending on the plan

Coverage still isn't automatic.

Why the indication matters

Insurance companies generally organize benefits around specific medical indications and billing categories.

Therefore, a prescription for weight management and a prescription associated with an approved sleep-apnea indication can be evaluated under different criteria.

If you have diagnosed obstructive sleep apnea, discuss the appropriate indication with your physician rather than assuming your weight-management benefit is the only possible route.

What About Cigna Medicare Plans?

Medicare coverage has additional restrictions.

Traditional Medicare Part D has historically excluded medications when prescribed solely for weight loss. However, FDA-approved indications beyond weight management can change how a medication is evaluated.

For someone enrolled in a Cigna Medicare Advantage plan with prescription coverage, the important distinction is the reason the medication is prescribed.

For example:

Weight-loss-only use may face exclusion
An approved indication such as obstructive sleep apnea may have a separate coverage pathway
Diabetes treatment involving tirzepatide is associated with Mounjaro rather than Zepbound

Because Medicare Advantage formularies and utilization rules vary, members should check their specific plan rather than relying on general Cigna coverage information.

What Happens When the Formulary Changes?

Insurance formularies aren't permanent.

A medication can move between tiers, become subject to additional authorization requirements, or have its preferred status changed.

If you're already taking Zepbound when your plan changes, don't immediately stop treatment.

Instead:

Review the new formulary notice.
Check whether a transition supply is available.
Ask your physician about a continuity-of-care exception.
Have your provider document your treatment history and response.
Appeal if appropriate.
Check your state's external-review options if the internal appeal is unsuccessful.

Keeping copies of your approval letters, prescriptions, weight records, and previous authorization decisions can make this process considerably easier.

Does Step Therapy Actually Help Patients?

It's easy to view step therapy as nothing more than an insurance roadblock. Sometimes it is frustrating, particularly when someone has already tried the required medication.

But there is a legitimate clinical argument for trying another treatment first.

Different patients respond differently to GLP-1-based medications. One person may tolerate semaglutide well and achieve meaningful results, while another may experience inadequate response or tolerability problems.

From an insurer's perspective, trying a preferred medication can reduce unnecessary spending.

The problem arises when step therapy is applied rigidly.

A patient who has already documented an unsuccessful trial shouldn't necessarily have to repeat the same treatment simply because the previous prescription came from another insurer or healthcare provider.

That's where the exception process becomes particularly important.

Practical Tips for Getting Zepbound Approved

1. Check your plan before the prescription is submitted

Ask Cigna or Express Scripts:

Is Zepbound on my formulary?
Is it covered for weight management?
Is prior authorization required?
Is step therapy required?
Which medications must I try first?
Is there an exception process?
What are the reauthorization requirements?

Write down the representative's name, date, and reference number for the call.

2. Give your doctor your complete medication history

Don't leave previous GLP-1 treatment off your intake form.

Tell your provider:

What medication you used
How long you used it
The highest dose reached
Whether it worked
Why you stopped
Any significant adverse effects

That information may be crucial for a step-therapy exception.

3. Know whether you're dealing with a denial or an exclusion

A denial can potentially be appealed.

An explicit benefit exclusion is a different problem.

Understanding the distinction can save you weeks of pursuing the wrong solution.

4. Keep your documentation organized

Create a simple folder containing:

Insurance correspondence
PA decisions
Appeal letters
Prescriptions
Weight records
Medication history
Physician notes

Insurance disputes become much easier when you have everything in one place.

5. Ask about the reason for every denial

Don't settle for "not covered."

Ask for the exact denial reason and the applicable policy or coverage criteria.

That tells you what to do next.

A Simple Decision Framework

Here's a practical way to approach the process.

If Zepbound is covered and you meet the criteria:
Work with your prescriber to complete the prior authorization accurately.

If step therapy is required:
Determine which medication must be tried and whether your previous treatment history qualifies for an exception.

If you've already tried another GLP-1:
Provide documentation before repeating the treatment.

If your plan excludes anti-obesity medications:
An ordinary PA may not solve the problem. Investigate whether another approved indication applies or discuss self-pay alternatives with your healthcare provider.

If coverage changed while you're already taking Zepbound:
Ask about transition supplies and continuity-of-care protections.

If your claim is denied:
Read the denial letter carefully before deciding whether to appeal.

The Bottom Line

Getting Zepbound covered by Cigna isn't simply a matter of asking whether Cigna "covers" the medication. The real answer depends on your specific formulary, employer benefit design, medical indication, prior authorization requirements, and whether step therapy applies.

Express Scripts is an important part of the process because it handles pharmacy-benefit administration for Cigna members. Understanding that relationship can help you send documentation and appeals to the right place.

Most importantly, don't treat every denial as a final answer. A step-therapy requirement may have an exception pathway. A missing piece of medical documentation can sometimes be corrected. A formulary change may allow for a continuity-of-care request.

At the same time, recognize when you're dealing with a genuine benefit exclusion. If your employer has opted out of anti-obesity medication coverage, the solution may need to come from the benefits side rather than another medical appeal.

The smartest approach is to identify the exact barrier first, gather the relevant documentation, and then use the appropriate coverage or appeal pathway. That can save significant time, money, and frustration while giving your healthcare provider the information needed to advocate for appropriate treatment.

Sources

Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM. 2022.
Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM. 2021.
Frias JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2). NEJM. 2021.
Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. NEJM. 2024.
FDA. Zepbound prescribing information. Updated 2024.
Cigna Pharmacy Drug List. Standard commercial formulary. 2026 edition.
Express Scripts. Clinical formulary management policy. 2026.
CMS. Part D Drug Coverage Determinations. Updated 2025.
NCQA. Step-therapy protocol standards for accreditation. 2024.
PwC Health Research Institute. Behind the Numbers: Health Plan Spend Drivers. 2024.
Eli Lilly. LillyDirect program for Zepbound self-pay. Accessed May 2026.
The Obesity Society. Step-therapy access barriers to AOMs. Position statement 2024.